Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review
- 1 June 2019
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 92, 109-117
Abstract
No abstract availableKeywords
Funding Information
- China Scholarship Council
- University of Toronto
- Canadian Association of Optometrists (201706010315)
This publication has 47 references indexed in Scilit:
- Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression?Journal of Psychopharmacology, 2013
- Reduced Reward Learning Predicts Outcome in Major Depressive DisorderBiological Psychiatry, 2013
- Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findingsJournal of Neurodevelopmental Disorders, 2012
- Treatment-resistant depression: therapeutic trends, challenges, and future directionsPatient Preference and Adherence, 2012
- Reduced Right Ventrolateral Prefrontal Cortex Activity While Inhibiting Positive Affect Is Associated with Improvement in Hedonic Capacity After 8 Weeks of Antidepressant Treatment in Major Depressive DisorderBiological Psychiatry, 2011
- Reconsidering anhedonia in depression: Lessons from translational neuroscienceNeuroscience & Biobehavioral Reviews, 2011
- Implications of the DSM's emphasis on sadness and anhedonia in major depressive disorderPsychiatry Research, 2008
- Assessing the effects of bupropion SR on mood dimensions of depressionJournal of Affective Disorders, 2004
- Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depressionJournal of Clinical Pharmacy and Therapeutics, 2000